Your browser doesn't support javascript.
loading
Approved Nanomedicine against Diseases.
Jia, Yuanchao; Jiang, Yuxin; He, Yonglong; Zhang, Wanting; Zou, Jiahui; Magar, Kosheli Thapa; Boucetta, Hamza; Teng, Chao; He, Wei.
Afiliação
  • Jia Y; Nanjing Vtrying Pharmatech Co., Ltd., Nanjing 211122, China.
  • Jiang Y; School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
  • He Y; School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
  • Zhang W; School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
  • Zou J; School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
  • Magar KT; School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
  • Boucetta H; School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
  • Teng C; School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
  • He W; School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Pharmaceutics ; 15(3)2023 Feb 26.
Article em En | MEDLINE | ID: mdl-36986635
ABSTRACT
Nanomedicine is a branch of medicine using nanotechnology to prevent and treat diseases. Nanotechnology represents one of the most effective approaches in elevating a drug's treatment efficacy and reducing toxicity by improving drug solubility, altering biodistribution, and controlling the release. The development of nanotechnology and materials has brought a profound revolution to medicine, significantly affecting the treatment of various major diseases such as cancer, injection, and cardiovascular diseases. Nanomedicine has experienced explosive growth in the past few years. Although the clinical transition of nanomedicine is not very satisfactory, traditional drugs still occupy a dominant position in formulation development, but increasingly active drugs have adopted nanoscale forms to limit side effects and improve efficacy. The review summarized the approved nanomedicine, its indications, and the properties of commonly used nanocarriers and nanotechnology.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2023 Tipo de documento: Article